Familial Nonmedullary Thyroid Cancer
- 1 June 2005
- journal article
- review article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 15 (6), 588-593
- https://doi.org/10.1089/thy.2005.15.588
Abstract
Familial nonmedullary thyroid cancer (FNMTC) is a syndrome of familial clustering of thyroid cancers of follicular cell origin. It is characterized by multifocality, early onset, more recurrences, and a higher degree of aggressiveness than nonfamilial thyroid cancers of follicular cell origin. An autosomal dominant inheritance pattern with reduced penetrance appears likely in most pedigrees. Although several candidate genes responsible for isolated clinical variants of FNMTC have been identified in single families, the gene(s) responsible for the vast majority of FNMTC cases has yet to be identified. Members of FNMTC cohorts should be followed longitudinally with physical examination and ultrasonography, and aggressively treated when cancer is diagnosed. When cancer is diagnosed, total thyroidectomy should be performed, and most patients should have a prophylactic central neck dissection and a therapeutic lateral functional neck dissection, postoperative radioiodine ablation and thyroid-stimulating hormone (TSH) suppressive therapy. Close follow-up with stimulated thyroglobulin levels, neck ultrasounds, and radioiodine scans are also central to the management strategy.Keywords
This publication has 55 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Mutations of the BRAF gene in human cancerNature, 2002
- Proximity of Chromosomal Loci That Participate in Radiation-Induced Rearrangements in Human CellsScience, 2000
- Genetic Heterogeneity in Familial Nonmedullary Thyroid Carcinoma: Exclusion of Linkage to RET, MNG1, and TCO in 56 FamiliesJournal of Clinical Endocrinology & Metabolism, 1999
- Familial Adenomatous Polyposis-Associated Thyroid Cancer: A Clinical, Pathological, and Molecular Genetics StudyThe American Journal of Pathology, 1999
- The ret/ptc1 Oncogene Is Activated in Familial Adenomatous Polyposis-Associated Thyroid Papillary CarcinomasJournal of Clinical Endocrinology & Metabolism, 1998
- Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomasEuropean Journal Of Cancer, 1994
- The Impact of Familial Adenomatous Polyposis on the Tumorigenesis and Mortality at the Several OrgansAnnals of Surgery, 1993
- Familial adenomatous polyposis (Gardner's syndrome) and thyroid carcinomaDigestive Diseases and Sciences, 1993
- Ataxia-Telangiectasia with Papillary Carcinoma of the ThyroidJournal of Pediatric Hematology/Oncology, 1986